Hydrogen-Bonding Assembly of Coordination Polymers Showing Reversible Dynamic Solid-State Structural Transformations

We herein report the synthesis, single-crystal structures of coordination polymers, and structural transformations of complexes employing 1,4,5,6-tetrahydro-5,6-dioxo-2,3-pyrazinedicarbonitrile (tdpd2−) and pyrazine (pyz) as bridging ligands. {[M(H2O)4(pyz)][M(tdpd)2(pyz)]·6(H2O)}n, [1·10H2O and 2·10H2O where M = Co (1) and Zn (2)], consists of two types of crystallographically independent one-dimensional (1D) structures packed together. One motif, [M(tdpd)2(pyz)]2− (A), is an anionic infinite pyz bridged 1D array with chelating tdpd2− ligands, and the other motif is a cationic chain, [M(H2O)4(pyz)]2+ (B), which is decorated with four terminal water molecules. The 1D arrays (A) and (B) are arranged in parallel by multi-point hydrogen-bonding interactions in an alternate (A)(B)(A)(B) sequence extending along the c-axis. Both compounds exhibit structural transformations driven by thermal dehydration processes around 350 K to give partially dehydrated forms, 1·2H2O and 2·2H2O. The structural determination of the partially dehydrated form, 2·2H2O, reveals a solid-state structural transformation from a 1D chain structure to a two-dimensional (2D) coordination sheet structure, [Zn2(tdpd)2(H2O)2(pyz)]n (2·2H2O). Further heating to 500 K yields the anhydrous form 2. While the virgin samples of 1·10H2O and 2·10H2O crystallize in different crystal systems, powder X-ray diffraction (PXRD) measurements of the dehydrated forms, 1·2H2O and 2·2H2O, are indicative of the same structure. The structural transformation is irreversible for 1·10H2O at ambient conditions. On the other hand, compound 2·10H2O shows a reversible structural change. The solid-state structural transformation for 1·10H2O was also confirmed by monitoring in-situ magnetic susceptibility, which is consistent with other thermally-induced measurements

Integrative analysis reveals early epigenetic alterations in high-grade serous ovarian carcinomas

Abstract High-grade serous ovarian carcinoma (HGSOC) is the most lethal gynecological malignancy. To date, the profiles of gene mutations and copy number alterations in HGSOC have been well characterized. However, the patterns of epigenetic alterations and transcription factor dysregulation in HGSOC have not yet been fully elucidated. In this study, we performed integrative omics analyses of a series of stepwise HGSOC model cells originating from human fallopian tube secretory epithelial cells (HFTSECs) to investigate early epigenetic alterations in HGSOC tumorigenesis. Assay for transposase-accessible chromatin using sequencing (ATAC-seq), chromatin immunoprecipitation sequencing (ChIP-seq), and RNA sequencing (RNA-seq) methods were used to analyze HGSOC samples. Additionally, protein expression changes in target genes were confirmed using normal HFTSECs, serous tubal intraepithelial carcinomas (STICs), and HGSOC tissues. Transcription factor motif analysis revealed that the DNA-binding activity of the AP-1 complex and GATA family proteins was dysregulated during early tumorigenesis. The protein expression levels of JUN and FOSL2 were increased, and those of GATA6 and DAB2 were decreased in STIC lesions, which were associated with epithelial-mesenchymal transition (EMT) and proteasome downregulation. The genomic region around the FRA16D site, containing a cadherin cluster region, was epigenetically suppressed by oncogenic signaling. Proteasome inhibition caused the upregulation of chemokine genes, which may facilitate immune evasion during HGSOC tumorigenesis. Importantly, MEK inhibitor treatment reversed these oncogenic alterations, indicating its clinical effectiveness in a subgroup of patients with HGSOC. This result suggests that MEK inhibitor therapy may be an effective treatment option for chemotherapy-resistant HGSOC